Home / Inspections / 1218824

FDA Inspection 1218824 — Shaanxi Hanjiang Pharmaceutical Group Co., Ltd (Gaoxin site)

Shaanxi Hanjiang Pharmaceutical Group Co., Ltd (Gaoxin site) — FEI 3003011617

The FDA completed an inspection of Shaanxi Hanjiang Pharmaceutical Group Co., Ltd (Gaoxin site) on September 21, 2023 in Hanzhong. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 21, 2023
Fiscal Year
2023
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Hanzhong (China)

Facility

Other inspections at this facility

  • 982472 (VAI Fri Jul 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 865961 (VAI Fri Dec 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 697592 (NAI Thu Oct 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 552585 (VAI Fri Nov 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources